ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO0714

Implementation of Strategies for Prevention and Control of SARS-CoV-2 Infection at Dialysis Units in Latin America: Analysis from GlomCon Latin America Working Group (LGlomCon)

Session Information

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)


  • Arellano-Mendez, Denisse, Unidad Medica de Atencion Ambulatoria 254, IMSS, Morelia, Michoacan, Mexico
  • Gutierrez-Prieto, Julio Alejandro, Hospital Central del Estado de Chihuahua, Chihuahua, Chihuahua, Mexico
  • Soto-Vargas, Javier, Hospital General Regional 46, IMSS, Guadalajara, Jalisco, Mexico
  • Martinez-Chagolla, Blanca, Hospital General “Dr. Miguel Silva", Morelia, Michoacan, Mexico
  • Cabeza Rivera, Franco H., University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Garcia Anton, Desiree, University of Mississippi Medical Center, Jackson, Mississippi, United States
  • Aguirre, Diana, Hospital General de Mexicali, Mexicali, Baja California, Mexico
  • Rodriguez Ramirez, Sonia, Multi-Organ Transplant Program, University Health Network, Toronto, Ontario, Canada
  • Avila-Casado, Carmen, Pathology Department, University Health Network, Toronto, Ontario, Canada

Group or Team Name

  • GlomCon Latin America Working Group

Patients on dialysis belong to the high-risk group to develop severe COVID-19 infection due to their multiple comorbidities. International societies have issued recommendations for the control and prevention of SARS-CoV-2 infection at dialysis units but implementing them may not always be feasible as many healthcare systems in Latin America (LA) have limited resources. This study aims to reflect the experience of nephrologists in LA at taking care of these patients and if the recommendations were adopted in their practices.


Descriptive analysis extracted from an online survey carried out among nephrologists, renal pathologists and other health workers treating kidney diseases between May 20-27, 2020 from sixteen Spanish speaking LA countries divided into 6 categories. We present the results for the ESRD category.


430 responses were obtained, 360 were considered for analysis. 276 (86.5%) of the participants were nephrologists and 178 (64%) of them practiced in dialysis units. 163 (92.6%) already implemented strategies to control and prevent COVID-19 in their units. 125 (71%) received training on it and 128 (72.7%) reported personal protective equipment availability. The most common implemented strategies were: education sessions about COVID-19 for patients and caregivers (68.5%), designated isolation areas (77.8%) or shifts (68.75%) for patients with suspected or confirmed COVID-19 and a 7-feet separation between hemodialysis (HD) machines (61.9%). 49 (28%) of the nephrologists reported an outbreak among patients and 60 (34.2%) among medical staff. Patient absenteeism to their HD sessions due to fear of infection, a decrease in the frequency and a shortening of the time of the sessions was reported in 41.7%, 30.2% and 36%, respectively. 29 (16.5%) of the respondents considered that those practices were associated with patient mortality.


Most dialysis units in LA are partially implementing the recommended strategies for control and prevention of COVID-19 but this seems to be insufficient since at least one third of them already faced outbreaks among patients and medical staff.